5329892026-01-012026-03-315329892026-03-315329892025-03-315329892025-04-012026-03-315329892026-01-012026-03-31in-capmkt:OtherExpenses1Member5329892026-01-012026-03-31in-capmkt:OtherExpenses2Member5329892025-04-012026-03-31in-capmkt:OtherExpenses1Member5329892025-04-012026-03-31in-capmkt:OtherExpenses2Member5329892026-03-31OtherNoncurrentFinancialAssetsDomain15329892026-03-31OtherCurrentFinancialAssetsDomain15329892026-03-31OtherCurrentAssetsDomain15329892026-03-31OtherNoncurrentLiabilitiesDomain15329892026-03-31OtherCurrentFinancialLiabilitiesDomain15329892026-03-31OtherCurrentLiabilitiesDomain15329892026-01-012026-03-31RelatedPartyTransactionDomain15329892025-12-31RelatedPartyTransactionDomain15329892026-03-31RelatedPartyTransactionDomain15329892026-01-012026-03-31RelatedPartyTransactionDomain25329892025-12-31RelatedPartyTransactionDomain25329892026-03-31RelatedPartyTransactionDomain25329892026-01-012026-03-31RelatedPartyTransactionDomain35329892025-12-31RelatedPartyTransactionDomain35329892026-03-31RelatedPartyTransactionDomain35329892026-01-012026-03-31RelatedPartyTransactionDomain45329892025-12-31RelatedPartyTransactionDomain45329892026-03-31RelatedPartyTransactionDomain45329892026-01-012026-03-31RelatedPartyTransactionDomain55329892025-12-31RelatedPartyTransactionDomain55329892026-03-31RelatedPartyTransactionDomain55329892026-01-012026-03-31RelatedPartyTransactionDomain65329892025-12-31RelatedPartyTransactionDomain65329892026-03-31RelatedPartyTransactionDomain65329892026-01-012026-03-31RelatedPartyTransactionDomain75329892025-12-31RelatedPartyTransactionDomain75329892026-03-31RelatedPartyTransactionDomain75329892026-01-012026-03-31RelatedPartyTransactionDomain85329892025-12-31RelatedPartyTransactionDomain85329892026-03-31RelatedPartyTransactionDomain85329892026-01-012026-03-31RelatedPartyTransactionDomain95329892025-12-31RelatedPartyTransactionDomain95329892026-03-31RelatedPartyTransactionDomain95329892026-01-012026-03-31RelatedPartyTransactionDomain105329892025-12-31RelatedPartyTransactionDomain105329892026-03-31RelatedPartyTransactionDomain105329892026-01-012026-03-31RelatedPartyTransactionDomain115329892025-12-31RelatedPartyTransactionDomain115329892026-03-31RelatedPartyTransactionDomain115329892026-01-012026-03-31RelatedPartyTransactionDomain125329892025-12-31RelatedPartyTransactionDomain125329892026-03-31RelatedPartyTransactionDomain125329892026-01-012026-03-31RelatedPartyTransactionDomain135329892025-12-31RelatedPartyTransactionDomain135329892026-03-31RelatedPartyTransactionDomain135329892026-01-012026-03-31RelatedPartyTransactionDomain145329892025-12-31RelatedPartyTransactionDomain145329892026-03-31RelatedPartyTransactionDomain145329892026-01-012026-03-31RelatedPartyTransactionDomain155329892025-12-31RelatedPartyTransactionDomain155329892026-03-31RelatedPartyTransactionDomain155329892026-01-012026-03-31RelatedPartyTransactionDomain165329892025-12-31RelatedPartyTransactionDomain165329892026-03-31RelatedPartyTransactionDomain165329892026-01-012026-03-31RelatedPartyTransactionDomain175329892025-12-31RelatedPartyTransactionDomain175329892026-03-31RelatedPartyTransactionDomain175329892026-01-012026-03-31RelatedPartyTransactionDomain185329892025-12-31RelatedPartyTransactionDomain185329892026-03-31RelatedPartyTransactionDomain185329892026-01-012026-03-31RelatedPartyTransactionDomain195329892025-12-31RelatedPartyTransactionDomain195329892026-03-31RelatedPartyTransactionDomain195329892026-01-012026-03-31RelatedPartyTransactionDomain205329892025-12-31RelatedPartyTransactionDomain205329892026-03-31RelatedPartyTransactionDomain205329892026-01-012026-03-31RelatedPartyTransactionDomain215329892025-12-31RelatedPartyTransactionDomain215329892026-03-31RelatedPartyTransactionDomain215329892026-01-012026-03-31RelatedPartyTransactionDomain225329892025-12-31RelatedPartyTransactionDomain225329892026-03-31RelatedPartyTransactionDomain225329892026-01-012026-03-31RelatedPartyTransactionDomain235329892025-12-31RelatedPartyTransactionDomain235329892026-03-31RelatedPartyTransactionDomain235329892026-01-012026-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares532989BAFNAPHNOTLISTEDINE878I01022BAFNA PHARMACEUTICALS LIMITEDMain BoardEquity2025-04-012026-03-312026-05-292026-05-21INRLakhsQuarterlyFourth quarterSingle segmentPharmaceuticals2026-05-2914:00:002026-05-2916:00:00trueCash Flow IndirectDeclaration of unmodified opiniontruetrueNANAfalsetrue2025-05-26http://bafnapharma.com/qualitypolicies.htmlfalsefalseThe Company has not defaulted on repayment of Loans and Debt Securities.2026-01-012026-03-31AuditedStandalone422393000176160004400090002139300000297110005443300010290000165990008885100041381400026195000026195000-12960000-1296000027491000000027491000382000031311000236563000101.161.16001.161.16Notes <BR> 1. The financial results were reviewed by the Audit Committee and were thereafter approved by the Board of Directors of the Company at their respective meetings held on 29th May, 2026. The statutory auditors have carried out the audit of the above financial results. <BR> 2. The figures for the quarter ended 31st March 2026 and preceding quarter ended 31st March 2025 are the balancing figures between the audited year to date figures for the year ended 31st March and the unaudited published figures for the nine months ended 31st December of the respective financial years. The figures for the corresponding previous periods have been regrouped and reclassified, wherever necessary, to make them comparable. <BR> 3. Company's business relates to the manufacturing of pharmaceuticals formations, which in context of Indian Accounting Standards 108 (Ind AS 108) as notified under Section 133 of the Companies Act, 2013 is considered as the only segment. <BR> 4. Exceptional items for the year ended 31st March 2025 represents the following <BR> (a) Derecognition of certain inventory items amounting to INR 37.56 Lakhs <BR> (b) Derecognition of Intangible Asset under Development amounting to INR 177 Lakhs. The management has derecognised the Intangible Asset under Development as it does not foresee that any future economic benefit would accrue to the Company in respect of the expenditure incurred in the earlier financial years towards obtaining certain product registrations. <BR> 5. The Company has received orders from the Goods and Services Tax authorities, including a demand order raising a GST liability amounting to INR 235.47 Lakhs and another order issued by the Joint Commissioner towards recovery of GST refunds availed during earlier years amounting to INR 331.09 Lakhs, along with applicable interest and penalty. The Company has preferred an appeal against the GST demand of INR 235.47 Lakhs. In respect of the recovery of GST refunds, the Company has obtained a stay for the amount of INR 331.09 Lakhs based on the writ petition before the Honorable High Court of Madras. Based on the underlying facts of the cases, applicable legal provisions, judicial precedents and prevailing industry practices, the Company is confident of prevailing against the positions adopted by the GST authorities and accordingly, does not anticipate any adverse financial outcome. <BR> 2025-04-012026-03-31AuditedStandalone15061740004756300015537370008213530000-1596000219189000366110006072600030775200014440350001097020000109702000-12960000-1296000011099800000001109980002433000113431000236563000107249320004.694.69004.694.69Manufacturing Expenses53728000Other Expenses35123000Manufacturing Expenses205082000Other Expenses1026700008179020003134000000000050000095560009561000085880300028903000004392920002024500007740001712500047743600010630001289920008965210000017553240002365630007249320009614950009614950001778220000001778220004161000003995000022193300019651100011325400019960500031285900024297000533667000233860001484300000571896000007938290001755324000Other non-current financial assets9556000Other Financial Assets17125000Other Current Assets128992000Government Grant39950000Other Financial Liabilities24297000Other Current Liabilities2338600036611000-8170000-363710000-49440000-543000-4302000034060000-5917000060726000059200000-20310000006790000000-7000-2909000040790000150492000000-3213000015370500000000000200000249028000000000000024139000000000067900000-2240100000000000092347000000361230000056224000-140810000-140810003432600020245000-3820000-24330000038200002433000BAFNA PHARMACEUTICALS LIMITED******Bafna Mahaveer Chand******Chief Executive OfficerRemuneration7800000Approved420000000BAFNA PHARMACEUTICALS LIMITED******Bafna Mahaveer Chand******Chief Executive OfficerLoanApproved0-15007000-15007000BAFNA PHARMACEUTICALS LIMITED******Bafna Mahaveer Chand******Chief Executive OfficerAny other transactionSalary AdvanceApproved20000002026-02-11200000000BAFNA PHARMACEUTICALS LIMITED******Bafna Mahaveer Chand******Chief Executive OfficerAny other transactionSalary Advance RepaymentApproved20000002026-02-11200000000BAFNA PHARMACEUTICALS LIMITED******Navin Bafna******Son of Chief Executive OfficerAny other transactionSalary For Rendering Services2800000Approved2720002026-05-29170200000BAFNA PHARMACEUTICALS LIMITED******Sasikala Bafna******Wife of Chief Executive OfficerAny other transactionRent1800000Approved88500000BAFNA PHARMACEUTICALS LIMITED******Shanmugam Hemalatha******Whole Time DirectorRemuneration2200000Approved1160002026-05-29131500000BAFNA PHARMACEUTICALS LIMITED******Vinayak Dinesh Dendukuri******Whole Time DirectorRemuneration4000000Approved182100000BAFNA PHARMACEUTICALS LIMITED******Melagiri Sridhar******Chief Financial OfficerRemuneration1700000Approved91200000BAFNA PHARMACEUTICALS LIMITED******Melagiri Sridhar******Chief Financial OfficerAny other transactionSalary AdvanceApproved028000035000BAFNA PHARMACEUTICALS LIMITED******Melagiri Sridhar******Chief Financial OfficerAny other transactionSalary Advance RepaymentApproved24500000BAFNA PHARMACEUTICALS LIMITED******Mohanachandran A******Company SecretaryRemuneration1400000Approved65100000BAFNA PHARMACEUTICALS LIMITED******Palamadai Krishnan Sundaresan******Independent DirectorAny other transactionSitting FeesApproved4400000BAFNA PHARMACEUTICALS LIMITED******Ravichandran Chitra******Independent DirectorAny other transactionSitting FeesApproved17800000BAFNA PHARMACEUTICALS LIMITED******Akila Chintalapati Raju******Non Executive DirectorAny other transactionSitting FeesApproved11100000BAFNA PHARMACEUTICALS LIMITED******Upendar Mekala Reddy******Non Executive DirectorAny other transactionSitting FeesApproved13300000BAFNA PHARMACEUTICALS LIMITED******Navin Kumar******Independent DirectorAny other transactionSitting FeesApproved13300000BAFNA PHARMACEUTICALS LIMITED******Bhansilal And Co******Entity in Which KMP is InterestedAny other transactionLease Rent12000Approved600000BAFNA PHARMACEUTICALS LIMITED******Mahaveer Chand Bafna HUF******Relative of KMPAny other transactionLease Rent6500000Approved300000000BAFNA PHARMACEUTICALS LIMITED******Novick Bio Sciences Private Limited******Entity in which a Director of the Company is InterestedSale of goods or servicesApproved12740002026-03-27127400000BAFNA PHARMACEUTICALS LIMITED******Novick Bio Sciences Private Limited******Entity in which a Director of the Company is InterestedSale of goods or servicesApproved1000002026-05-2910000000BAFNA PHARMACEUTICALS LIMITED******Novick Bio Sciences Private Limited******Entity in which a Director of the Company is InterestedSale of goods or servicesApproved84300002026-05-29843000000BAFNA PHARMACEUTICALS LIMITED******Rexa Insurance Broking Services Private Limited******Entity in which a Director of the Company is InterestedPurchase of goods or servicesApproved9630002026-03-279630000030103000AuditedtrueBrahmayya & Cotrue2027-04-30